Quarterly Result14 May 2025, 05:52 pm
Blue Jet Healthcare Announces Q4 & FY25 Results: Highest Q4 Revenue at Rs. 3,404 mn; a jump of 85.1% YoY
AI Summary
Blue Jet Healthcare Limited (BLUEJET) reported financial results for the quarter and year ended March 31, 2025. The company recorded a revenue of Rs. 10,300 Mn with 44.7% growth YoY and highest ever EBITDA achieved of Rs. 3,777 Mn for the year. The quarter saw a revenue of Rs. 3,404 and EBITDA at Rs. 1,400 Mn. The growth was mainly led by the Pharmaceutical Intermediate & API Business. The Board of directors have proposed a dividend of Rs. 1.2 per share for the year.
Key Highlights
- Revenue from operations for Q4 FY25 stood at Rs. 3,404 mn, up 85.1% YoY
- Highest ever EBITDA for the quarter came at Rs. 1,400 mn, up 163.7% YoY
- EBITDA margin for the quarter came at 41.1%, up 1,226 bps YoY
- PAT for the quarter was at Rs. 1,101 mn, up 177.7% YoY
- PAT margin for the quarter came at 32.3%, up 1,078 bps YoY